Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Esophageal Neoplasms 5Barrett Esophagus 3Pancreatic Neoplasms 2Neoplasms 2Lung Neoplasms 2Stomach Neoplasms 1Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Breath Test 1Breast Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Carboplatin 345Cisplatin 240Paclitaxel 208Radiotherapy 206Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 146Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 101Etoposide 98Bevacizumab 96Specimen Handling 84Nivolumab 77durvalumab 73Radiosurgery 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 44Biopsy 43Irinotecan 42Radiation 41Topotecan 39Standard of Care 38Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lung Neoplasms × Breath Tests × Clear all
NCT04419207 2022-04-20

Detecting Lung Cancer Based on Exhaled Breath

Peking University People's Hospital

Completed
2,236 enrolled
Thoracic

Carcinoma, Lung Neoplasms

NCT03275688 2020-07-22

NanoSpectrometer Biomarker Discovery and Confirmation Study

Johns Hopkins University

Terminated
332 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡